Related references
Note: Only part of the references are listed.International Increases in Merkel Cell Carcinoma Incidence Rates between 1997 and 2016
Catherine M. Olsen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma
Miranda C. Lahman et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Discovery of synthetic lethal and tumor suppressor paralog pairs in the human genome
Phoebe C. R. Parrish et al.
CELL REPORTS (2021)
Small Molecule Inhibition of GSK-3 Specifically Inhibits the Transcription of Inhibitory Co-receptor LAG-3 for Enhanced Anti-tumor Immunity
Christopher E. Rudd et al.
CELL REPORTS (2020)
Promoter activity of Merkel cell Polyomavirus variants in human dermal fibroblasts and a Merkel cell carcinoma cell line
Ibrahim Abdulsalam et al.
VIROLOGY JOURNAL (2020)
Merkel Cell Polyomavirus and Merkel Cell Carcinoma
Valeria Pietropaolo et al.
CANCERS (2020)
The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment
Giuseppa Augello et al.
CELLS (2020)
Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration
David Schrama et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy
Paul Nghiem et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Properties of FDA-approved small molecule protein kinase inhibitors
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling
Felicitas Bossler et al.
MBIO (2019)
Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia
Brent M. Kuenzi et al.
SCIENTIFIC REPORTS (2019)
Intra-patient viral evolution in polyomavirus-related diseases
Dorian McIlroy et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2019)
Efficacy and Safety of Glycogen Synthase Kinase 3 Inhibitors for Alzheimer's Disease: A Systematic Review and Meta-Analysis
Shinji Matsunaga et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Immune Checkpoint Inhibitors and Beyond: An Overview of Immune-Based Therapies in Merkel Cell Carcinoma
Mahtab Samimi
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2019)
Kinase inhibitors: the road ahead
Fleur M. Ferguson et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC
Juergen C. Becker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Protein-mediated viral latency is a novel mechanism for Merkel cell polyomavirus persistence
Hyun Jin Kwun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Activation of Wnt/β-catenin signalling via GSK3 inhibitors direct differentiation of human adipose stem cells into functional hepatocytes
Jieqiong Huang et al.
SCIENTIFIC REPORTS (2017)
Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8+ Cytotoxic T-Cells: Implications for anti-PD-1 Immunotherapy
Alison Taylor et al.
FRONTIERS IN IMMUNOLOGY (2017)
Merkel Cell Polyomavirus Small T Antigen Initiates Merkel Cell Carcinoma-like Tumor Development in Mice
Monique E. Verhaegen et al.
CANCER RESEARCH (2017)
Merkel Cell Carcinoma Therapeutic Update
Nicole M. Cassler et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8+ Cytolytic T Cell Responses
Alison Taylor et al.
IMMUNITY (2016)
Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base
Shailender Bhatia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
Paul T. Nghiem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells
Sonja Hesbacher et al.
ONCOTARGET (2016)
Cytoplasmic NOTCH and membrane derived β-catenin link cell fate choice to epithelial-mesenchymal transition during myogenesis
Daniel Sieiro et al.
ELIFE (2016)
Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base
Shailender Bhatia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Merkel cell polyomavirus T antigens promote cell proliferation and inflammatory cytokine gene expression
Kathleen F. Richards et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Early and late promoters of BK polyomavirus, Merkel cell polyomavirus, Trichodysplasia spinulosa-associated polyomavirus and human polyomavirus 12 are among the strongest of all known human polyomaviruses in 10 different cell lines
Ugo Moens et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Merkel Cell Polyomavirus Small T Antigen Is Oncogenic in Transgenic Mice
Monique E. Verhaegen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
FDA-approved small-molecule kinase inhibitors
Peng Wu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Characterization of functional domains in the Merkel cell polyoma virus Large T antigen
Roland Houben et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
The HSP70 Modulator MAL3-101 Inhibits Merkel Cell Carcinoma
Christian Adam et al.
PLOS ONE (2014)
Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Cells Do Not Require Expression of the Viral Small T Antigen
Sabrina Angermeyer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells
Roland Houben et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus
Scott J. Rodig et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Pyruvate Kinase M2 Regulates Gene Transcription by Acting as a Protein Kinase
Xueliang Gao et al.
MOLECULAR CELL (2012)
Glycogen Synthase Kinase 3 (GSK3) Inhibitor, SB-216763, Promotes Pluripotency in Mouse Embryonic Stem Cells
Leslie A. Kirby et al.
PLOS ONE (2012)
Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator
Masahiro Shuda et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
GSK3 inhibitors enhance retinoic acid receptor activity and induce the differentiation of retinoic acid-sensitive myeloid leukemia cells
J. Si et al.
LEUKEMIA (2011)
Real-Time Observation of Wnt beta-Catenin Signaling in the Chick Embryo
Anne C. Rios et al.
DEVELOPMENTAL DYNAMICS (2010)
Glycogen synthase kinase 3β mediates high glucose-induced ubiquitination and proteasome degradation of insulin receptor substrate 1
Sanhua Leng et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens
Roland Houben et al.
JOURNAL OF VIROLOGY (2010)
GSK3: a multifaceted kinase in Wnt signaling
Dianqing Wu et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Glycogen synthase kinase 3: more than a namesake
Geetha Vani Rayasam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
MC Polyomavirus Is Frequently Present in Merkel Cell Carcinoma of European Patients
Juergen C. Becker et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Quantitation of Human Seroresponsiveness to Merkel Cell Polyomavirus
Diana V. Pastrana et al.
PLOS PATHOGENS (2009)
Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene
Ahmad Kassem et al.
CANCER RESEARCH (2008)
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus
Masahiro Shuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Clonal integration of a polyomavirus in human Merkel cell carcinoma
Huichen Feng et al.
SCIENCE (2008)
Regulation of gene transcription by mitogen-activated protein kinase signaling pathways
Alan J. Whitmarsh
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Functional redundancy of GSK-3α and GSK-3β in Wnt/β-catenin signaling shown by using an allelic series of embryonic stem cell lines
Bradley W. Doble et al.
DEVELOPMENTAL CELL (2007)
Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1α and mediates its destabilization in a VHL-independent manner
Daniela Fluegel et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase
WY Wei et al.
CANCER CELL (2005)
Interaction between JCV large T-antigen and β-catenin
DD Gan et al.
ONCOGENE (2004)
Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo
DB Ring et al.
DIABETES (2003)
Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase
A Woods et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
